Status
Conditions
Treatments
About
The OL1000 is intended to be used as a non-invasive adjunctive treatment for adult males or females that have sustained a closed, unstable ankle fracture that requires surgical treatment for stabilization. The initiation of the adjunctive treatment is to begin within 11 days of surgical stabilization.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
217 participants in 2 patient groups
Loading...
Central trial contact
Akujuobi Udu, MS; Jessica Knowlton, MS
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal